Glezer Eli N. 4
4 · Singular Genomics Systems, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Glezer Eli N.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-15+7,500→ 4,585,000 total - Exercise/Conversion
Restricted Stock Units
2024-03-15−7,500→ 90,000 total→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.